Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02039206 | The Influence of Deep TMS on Cerebellar Signs in Patients With Machado Joseph Disease | PHASE2 | COMPLETED | 20 | — | — | Feb 1, 2014 | Jun 1, 2016 | Jan 25, 2018 | 1 | Israel |
| Arm | Type | Description |
|---|---|---|
| Treatment | EXPERIMENTAL | Deep TMS |
| Name | Type | Description |
|---|---|---|
| Deep TMS | DEVICE | 1Hz Stimulation |
Inclusion Criteria: * SCA3 patients aged 20 - 80 years, with detectable clinical signs and confirmed genetic diagnosis. Exclusion Criteria: 1. Patients who have concomitant epilepsy. 2. History of seizure or heat convulsion. 3. Patients on neuroleptics. 4. Patients with dementia (MMSE\<25) or any...